Clinical Trial Update: An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects [Phase 2]

View source ↗

Summary

A Phase 2, open-label, non-controlled, single-group trial in adolescents with psoriasis vulgaris completed, with results posted by LEO Pharma to assess the expe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Not disclosed

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2018-11-06